arrow
T

Tamar S. Polonsky

internal medicine
H指数:36
被引数:7,191

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Community-based recruitment with ankle brachial index testing to identify peripheral artery disease participants for randomized clinical trials

社区招募结合踝臂指数测试以识别随机临床试验的周围动脉疾病受试者

2026-04-240
PRE
Hepatocyte growth factor for walking performance in peripheral artery disease

肝细胞生长因子对周围动脉病行走功能的影响

2025-06-160
PRE
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia
2025-04-010
OAAI
The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease
2024-09-060
PRE
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients

阿司匹林用于男性和女性患者动脉粥样硬化性心血管疾病二级预防的剂量

2024-09-011
PRE
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease

年龄和阿司匹林剂量在动脉粥样硬化性心血管疾病二级预防中的作用

2024-02-201
OAAI
Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis

动脉粥样硬化多民族研究中小密低密度脂蛋白胆固醇与冠状动脉钙化

2024-02-071
OA
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia
2023-12-2867
OA
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
2023-11-014
OAAI
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors

阿司匹林剂量用于P2Y12抑制剂治疗患者动脉粥样硬化性心血管疾病的二级预防

2023-10-171
OAAI